The Future of Patent Protection for Post-FDA-Approved Generics: A Look at the Federal Circuit’s Incongruous Interpretations of the “Safe Harbor” Provision in 35 U.S.C. § 271(e)(1)

Authors

Alexandra Robertson

Recommended Citation

Robertson, Alexandra (2014) "The Future of Patent Protection for Post-FDA-Approved Generics: A Look at the Federal Circuit’s Incongruous Interpretations of the “Safe Harbor” Provision in 35 U.S.C. § 271(e)(1)," Seton Hall Circuit Review: Vol. 10: Iss. 2, Article 7.
Available at: https://scholarship.shu.edu/circuit_review/vol10/iss2/7